Life sciences
Life Sciences and Health Care services are facing many challenges and are dramatically changing: declining R&D productivity and loss of exclusivity; decreasing government budgets for new drugs and devices; as well as increasing regulatory scrutiny; have all combined to make it increasingly difficult to maximise revenues from in-line products.
In the years to come, huge innovative changes can be expected with new types of partnerships throughout the whole life cycle of a drug. It is clear that drug making is no longer the core business of Life Sciences’ companies. Their focus is increasingly shifting to total health solutions for a disease area.
We have expertise in the following areas:
In the years to come, huge innovative changes can be expected with new types of partnerships throughout the whole life cycle of a drug. It is clear that drug making is no longer the core business of Life Sciences’ companies. Their focus is increasingly shifting to total health solutions for a disease area.
We have expertise in the following areas:
- - Pharmaceuticals
- Generics
- Consumer Health
- Medical Devices & Diagnostics
- Medical Equipment & Technology
